Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics

World Health Organization Leishmaniasis http://www.who.int/leishmaniasis/en/

Desjeux, 2004, Leishmaniasis: current situation and new perspectives, Comp Immunol Microbiol Infect Dis, 27, 305, 10.1016/j.cimid.2004.03.004

Wright, 2008, Cutaneous leishmaniasis in Texas : a northern spread of endemic areas, J Am Acad Dermatol, 58, 650, 10.1016/j.jaad.2007.11.008

Bailey, 2005, Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel, J R Army Med Corps, 151, 73, 10.1136/jramc-151-02-03

Lawn, 2004, New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers, QJM, 97, 781, 10.1093/qjmed/hch127

Pasquau, 2005, Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterranean region, Eur J Clin Micrbiol Infect Dis, 24, 411, 10.1007/s10096-005-1342-6

Couppie, 2004, Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana, Br J Dermatol, 151, 1165, 10.1111/j.1365-2133.2004.06226.x

Reed, 1993, T-cell and cytokine responses in leishmaniasis, Curr Opin Immunol, 5, 524, 10.1016/0952-7915(93)90033-O

Andrade-Narvaez, 2005, The histopathology of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico, Rev Inst Med Trop Sao Paulo, 47, 191, 10.1590/S0036-46652005000400003

Ramírez, 2000, Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis, J Clin Microbiol, 38, 3768, 10.1128/JCM.38.10.3768-3773.2000

Boggild, 2008, Optimization of microculture and evaluation of miniculture for the isolation of Leishmania parasites from cutaneous lesions in Peru, Am J Trop Med Hyg, 79, 847, 10.4269/ajtmh.2008.79.847

Reithinger, 2007, Molecular diagnosis of leishmaniasis: current status and future applications, J Clin Microbiol, 45, 21, 10.1128/JCM.02029-06

Carter, 2006, Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase, Antimicrob Agents Chemother, 50, 88, 10.1128/AAC.50.1.88-95.2006

Gonzalez, 2008, Interventions for Old World cutaneous leishmaniasis, Cochrane Database Syst Rev, CD005067

Gonzalez, 2009, Interventions for American cutaneous and mucocutaneous leishmaniasis), Cochrane Database Syst Rev, CD004834

Ameen, 2007, Cutaneous leishmaniasis. therapeutic strategies and future directions, Expert Opin Pharmacother, 8, 2689, 10.1517/14656566.8.16.2689

Gurei, 2000, Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis, J Egypt Soc Parasitol, 30, 169

Van Der Snoek, 2008, A review of photodynamic therapy in cutaneous leishmaniasis, J Eur Acad Dermatol Venereol, 22, 918, 10.1111/j.1468-3083.2008.02805.x

Akilov, 2007, Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells, Exp Dermatol, 16, 651, 10.1111/j.1600-0625.2007.00578.x

Pizinger, 2009, Successful treatment of cutaneous leishmaniasis by photodynamic therapy and cryotherapy, Eur J Dermatol, 19, 172, 10.1684/ejd.2008.0587

Harms, 1991, A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis, Trans R Soc Trop Med Hyg, 85, 214, 10.1016/0035-9203(91)90026-U

Santos, 2004, Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous leishmaniasis ulcers: a randomized, double-blind placebo-controlled study, J Infect Dis, 190, 1793, 10.1086/424848

Buates, 1999, Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action, J Infect Dis, 179, 1485, 10.1086/314782

Miranda-Verastegui, 2009, First-Line Therapy for Human Cutaneous Leishman in Peru using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony, PLoS Negl Trop Dis, 3, e491, 10.1371/journal.pntd.0000491

Firooz, 2006, Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis, Arch Dermatol, 142, 1575, 10.1001/archderm.142.12.1575

Kubar, 2005, Recombinant DNA-derived Leishmania proteins: from the laboratory to the field, Lancet Infect Dis, 5, 107, 10.1016/S1473-3099(05)01282-X

Kamhawi, 2000, Protection against cutaneous leishmaniasis resulting from bites of uninfected sandflies, Science, 290, 1351, 10.1126/science.290.5495.1351

Stober, 2006, From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection, Vaccine, 24, 2602, 10.1016/j.vaccine.2005.12.012

Convit, 2004, Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin - preliminary report, Mem Inst Oswaldo Cruz, 91, 57, 10.1590/S0074-02762004000100010